July 2022 / Switzerland
The Producer and Import Price Index rose in June 2022 by 0.3% compared with the previous month, reaching 109.8 points (December 2020 = 100). Petroleum products in particular were more expensive. Compared with June 2021, the price level of the whole range of domestic and imported products rose by 6.9%. These are the results from the Federal Statistical Office (FSO).
In particular, higher prices for builders' and interiors’ joinery as well as petroleum products were responsible for the increase in the producer price index compared with the previous month. Increasing prices were also seen for gas and dairy products. In contrast, scrap became cheaper.
The import price index registered higher prices compared with May 2022, particularly for petroleum products. Furthermore, motor vehicles and motor vehicle parts, builders' and interiors’ joinery, computers, other transport equipment, leather and travel goods also became more expensive. In contrast, basic metals and semi-finished metal products as well as petroleum and natural gas saw lower prices.
You can find further information in the press release.
On 22 July 2022, Italy and Switzerland released a joint declaration (in Italian) extending the mutual agreement, signed on 18 and 19 June 2020, regarding the taxation of frontier workers during the COVID-19 pandemic.
The mutual agreement will continue to apply until 31 October 2022, despite the end of the COVID-19 pandemic. This will allow the Italian and Swiss competent authorities to consult each other in order to verify whether the conditions for the application of the mutual agreement continue to exist.
The close collaboration between science and industry is unique in Switzerland: Companies in the life sciences sector benefit from fast technology transfer in an innovative ecosystem, driven by cutting-edge research from Swiss-based pharmaceutical companies.
Thanks to its traditional strength in the life sciences sector and international ICT hotspots, Switzerland offers the ideal environment for innovative companies that want to quickly and easily bring new innovations in personalized health to market. In Switzerland, science and industry have a uniquely close relationship that guarantees fast technology transfer in a versatile and compact ecosystem. Cutting-edge research is carried out by Swiss pharmaceutical companies such as Roche and Novartis, at world-class universities and government institutes; SMEs and startups provide important impetus for this. Switzer-land is investing massively in harmonized data infrastructures, while at the same time placing great importance on data protection.
Fact sheet: Switzerland - a hub for personalized health